| Year |
Citation |
Score |
| 2024 |
Okubo T, Rivron N, Kabata M, Masaki H, Kishimoto K, Semi K, Nakajima-Koyama M, Kunitomi H, Kaswandy B, Sato H, Nakauchi H, Woltjen K, Saitou M, Sasaki E, Yamamoto T, et al. Publisher Correction: Hypoblast from human pluripotent stem cells regulates epiblast development. Nature. 626: E21. PMID 38347193 DOI: 10.1038/s41586-024-07166-w |
0.385 |
|
| 2023 |
Okubo T, Rivron N, Kabata M, Masaki H, Kishimoto K, Semi K, Nakajima-Koyama M, Kunitomi H, Kaswandy B, Sato H, Nakauchi H, Woltjen K, Saitou M, Sasaki E, Yamamoto T, et al. Hypoblast from human pluripotent stem cells regulates epiblast development. Nature. PMID 38052228 DOI: 10.1038/s41586-023-06871-2 |
0.362 |
|
| 2023 |
Otomo J, Woltjen K, Sakurai H. Uniform transgene activation in Tet-On systems depends on sustained rtTA expression. Iscience. 26: 107685. PMID 37701566 DOI: 10.1016/j.isci.2023.107685 |
0.361 |
|
| 2023 |
Kubiura-Ichimaru M, Penfold C, Kojima K, Dollet C, Yabukami H, Semi K, Takashima Y, Boroviak T, Kawaji H, Woltjen K, Minoda A, Sasaki E, Watanabe T. mRNA-based generation of marmoset PGCLCs capable of differentiation into gonocyte-like cells. Stem Cell Reports. 18: 1987-2002. PMID 37683645 DOI: 10.1016/j.stemcr.2023.08.006 |
0.411 |
|
| 2022 |
Ueda T, Shiina S, Iriguchi S, Terakura S, Kawai Y, Kabai R, Sakamoto S, Watanabe A, Ohara K, Wang B, Xu H, Minagawa A, Hotta A, Woltjen K, Uemura Y, et al. Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells. Nature Biomedical Engineering. 7: 24-37. PMID 36509913 DOI: 10.1038/s41551-022-00969-0 |
0.304 |
|
| 2021 |
Taguchi J, Shibata H, Kabata M, Kato M, Fukuda K, Tanaka A, Ohta S, Ukai T, Mitsunaga K, Yamada Y, Nagaoka SI, Yamazawa S, Ohnishi K, Woltjen K, Ushiku T, et al. DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency. Nature Communications. 12: 5041. PMID 34413299 DOI: 10.1038/s41467-021-25249-4 |
0.325 |
|
| 2021 |
Io S, Kabata M, Iemura Y, Semi K, Morone N, Minagawa A, Wang B, Okamoto I, Nakamura T, Kojima Y, Iwatani C, Tsuchiya H, Kaswandy B, Kondoh E, Kaneko S, ... Woltjen K, et al. Capturing human trophoblast development with naive pluripotent stem cells in vitro. Cell Stem Cell. PMID 33831365 DOI: 10.1016/j.stem.2021.03.013 |
0.312 |
|
| 2020 |
Maurissen TL, Woltjen K. Synergistic gene editing in human iPS cells via cell cycle and DNA repair modulation. Nature Communications. 11: 2876. PMID 32513994 DOI: 10.1038/s41467-020-16643-5 |
0.316 |
|
| 2020 |
Matsuda M, Yamanaka Y, Uemura M, Osawa M, Saito MK, Nagahashi A, Nishio M, Guo L, Ikegawa S, Sakurai S, Kihara S, Maurissen TL, Nakamura M, Matsumoto T, Yoshitomi H, ... ... Woltjen K, et al. Recapitulating the human segmentation clock with pluripotent stem cells. Nature. 580: 124-129. PMID 32238941 DOI: 10.1038/s41586-020-2144-9 |
0.382 |
|
| 2019 |
Sakakura M, Ohta S, Yagi M, Tanaka A, Norihide J, Woltjen K, Yamamoto T, Yamada Y. Smarcb1 maintains the cellular identity and the chromatin landscapes of mouse embryonic stem cells. Biochemical and Biophysical Research Communications. PMID 31543342 DOI: 10.1016/j.bbrc.2019.09.054 |
0.358 |
|
| 2019 |
Komura S, Ito K, Ohta S, Ukai T, Kabata M, Itakura F, Semi K, Matsuda Y, Hashimoto K, Shibata H, Sone M, Jo N, Sekiguchi K, Ohno T, Akiyama H, ... ... Woltjen K, et al. Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas. Nature Communications. 10: 3999. PMID 31488818 DOI: 10.1038/S41467-019-11745-1 |
0.349 |
|
| 2018 |
Kagawa H, Shimamoto R, Kim SI, Oceguera-Yanez F, Yamamoto T, Schroeder T, Woltjen K. OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates. Stem Cell Reports. PMID 30639212 DOI: 10.1016/j.stemcr.2018.12.008 |
0.421 |
|
| 2018 |
Kim SI, Matsumoto T, Kagawa H, Nakamura M, Hirohata R, Ueno A, Ohishi M, Sakuma T, Soga T, Yamamoto T, Woltjen K. Microhomology-assisted scarless genome editing in human iPSCs. Nature Communications. 9: 939. PMID 29507284 DOI: 10.1038/s41467-018-03044-y |
0.339 |
|
| 2017 |
Kojima Y, Sasaki K, Yokobayashi S, Sakai Y, Nakamura T, Yabuta Y, Nakaki F, Nagaoka S, Woltjen K, Hotta A, Yamamoto T, Saitou M. Evolutionarily Distinctive Transcriptional and Signaling Programs Drive Human Germ Cell Lineage Specification from Pluripotent Stem Cells. Cell Stem Cell. 21: 517-532.e5. PMID 28985527 DOI: 10.1016/J.Stem.2017.09.005 |
0.374 |
|
| 2017 |
Kieffer TJ, Woltjen K, Osafune K, Yabe D, Inagaki N. Beta-cell replacement strategies for diabetes. Journal of Diabetes Investigation. PMID 28984038 DOI: 10.1111/jdi.12758 |
0.318 |
|
| 2016 |
Komura S, Semi K, Itakura F, Shibata H, Ohno T, Hotta A, Woltjen K, Yamamoto T, Akiyama H, Yamada Y. An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development. Stem Cell Reports. PMID 26997645 DOI: 10.1016/J.Stemcr.2016.02.009 |
0.319 |
|
| 2015 |
Oceguera-Yanez F, Kim SI, Matsumoto T, Tan GW, Long X, Hatani T, Kondo T, Ikeya M, Yoshida Y, Inoue H, Woltjen K. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives. Methods (San Diego, Calif.). PMID 26707206 DOI: 10.1016/j.ymeth.2015.12.012 |
0.41 |
|
| 2015 |
Tamaki S, Fukuta M, Sekiguchi K, Jin Y, Nagata S, Hayakawa K, Hineno S, Okamoto T, Watanabe M, Woltjen K, Ikeya M, Kato T, Toguchida J. SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier. Plos One. 10: e0142991. PMID 26571495 DOI: 10.1371/journal.pone.0142991 |
0.321 |
|
| 2015 |
Chantzoura E, Skylaki S, Menendez S, Kim SI, Johnsson A, Linnarsson S, Woltjen K, Chambers I, Kaji K. Reprogramming Roadblocks Are System Dependent. Stem Cell Reports. 5: 350-64. PMID 26278041 DOI: 10.1016/J.Stemcr.2015.07.007 |
0.306 |
|
| 2015 |
Sasaki K, Yokobayashi S, Nakamura T, Okamoto I, Yabuta Y, Kurimoto K, Ohta H, Moritoki Y, Iwatani C, Tsuchiya H, Nakamura S, Sekiguchi K, Sakuma T, Yamamoto T, Mori T, ... Woltjen K, et al. Robust In Vitro Induction of Human Germ Cell Fate from Pluripotent Stem Cells. Cell Stem Cell. 17: 178-94. PMID 26189426 DOI: 10.1016/j.stem.2015.06.014 |
0.396 |
|
| 2015 |
Woltjen K, Kim SI, Nagy A. The piggyBac Transposon as a Platform Technology for Somatic Cell Reprogramming Studies in Mouse. Methods in Molecular Biology (Clifton, N.J.). PMID 26126450 DOI: 10.1007/7651_2015_274 |
0.55 |
|
| 2015 |
Kim SI, Oceguera-Yanez F, Sakurai C, Nakagawa M, Yamanaka S, Woltjen K. Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons. Methods in Molecular Biology (Clifton, N.J.). PMID 26025620 DOI: 10.1007/7651_2015_251 |
0.463 |
|
| 2015 |
Shoji E, Woltjen K, Sakurai H. Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells. Methods in Molecular Biology (Clifton, N.J.). PMID 25971915 DOI: 10.1007/7651_2015_257 |
0.416 |
|
| 2014 |
Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T, Soejima H, Moriwaki H, Yamanaka S, Woltjen K, Yamada Y. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell. 156: 663-77. PMID 24529372 DOI: 10.1016/j.cell.2014.01.005 |
0.301 |
|
| 2013 |
Yamashita A, Liu S, Woltjen K, Thomas B, Meng G, Hotta A, Takahashi K, Ellis J, Yamanaka S, Rancourt DE. Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells. Scientific Reports. 3: 1978. PMID 23760219 DOI: 10.1038/srep01978 |
0.586 |
|
| 2013 |
Tanaka A, Woltjen K, Miyake K, Hotta A, Ikeya M, Yamamoto T, Nishino T, Shoji E, Sehara-Fujisawa A, Manabe Y, Fujii N, Hanaoka K, Era T, Yamashita S, Isobe K, et al. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. Plos One. 8: e61540. PMID 23626698 DOI: 10.1371/journal.pone.0061540 |
0.389 |
|
| 2013 |
Sakuma T, Hosoi S, Woltjen K, Suzuki K, Kashiwagi K, Wada H, Ochiai H, Miyamoto T, Kawai N, Sasakura Y, Matsuura S, Okada Y, Kawahara A, Hayashi S, Yamamoto T. Efficient TALEN construction and evaluation methods for human cell and animal applications. Genes to Cells : Devoted to Molecular & Cellular Mechanisms. 18: 315-26. PMID 23388034 DOI: 10.1111/gtc.12037 |
0.392 |
|
| 2013 |
Hayakawa K, Ikeya M, Fukuta M, Woltjen K, Tamaki S, Takahara N, Kato T, Sato S, Otsuka T, Toguchida J. Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells. Biochemical and Biophysical Research Communications. 432: 713-9. PMID 23313505 DOI: 10.1016/j.bbrc.2013.01.003 |
0.364 |
|
| 2012 |
Michael IP, Monetti C, Chiu AC, Zhang P, Baba T, Nishino K, Agha-Mohammadi S, Woltjen K, Sung HK, Nagy A. Highly efficient site-specific transgenesis in cancer cell lines. Molecular Cancer. 11: 89. PMID 23231822 DOI: 10.1186/1476-4598-11-89 |
0.454 |
|
| 2011 |
Gabut M, Samavarchi-Tehrani P, Wang X, Slobodeniuc V, O'Hanlon D, Sung HK, Alvarez M, Talukder S, Pan Q, Mazzoni EO, Nedelec S, Wichterle H, Woltjen K, Hughes TR, Zandstra PW, et al. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell. 147: 132-46. PMID 21924763 DOI: 10.1016/J.Cell.2011.08.023 |
0.526 |
|
| 2011 |
Woltjen K, Hämäläinen R, Kibschull M, Mileikovsky M, Nagy A. Transgene-free production of pluripotent stem cells using piggyBac transposons. Methods in Molecular Biology (Clifton, N.J.). 767: 87-103. PMID 21822869 DOI: 10.1007/978-1-61779-201-4_7 |
0.599 |
|
| 2011 |
Nagy K, Sung HK, Zhang P, Laflamme S, Vincent P, Agha-Mohammadi S, Woltjen K, Monetti C, Michael IP, Smith LC, Nagy A. Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Reviews. 7: 693-702. PMID 21347602 DOI: 10.1007/S12015-011-9239-5 |
0.57 |
|
| 2011 |
Monetti C, Nishino K, Biechele S, Zhang P, Baba T, Woltjen K, Nagy A. PhiC31 integrase facilitates genetic approaches combining multiple recombinases. Methods (San Diego, Calif.). 53: 380-5. PMID 21185379 DOI: 10.1016/J.Ymeth.2010.12.023 |
0.527 |
|
| 2010 |
Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A, Woltjen K, Nagy A, Wrana JL. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell. 7: 64-77. PMID 20621051 DOI: 10.1016/J.Stem.2010.04.015 |
0.512 |
|
| 2010 |
O'Malley J, Woltjen K, Kaji K. New strategies to generate induced pluripotent stem cells. Current Opinion in Biotechnology. 20: 516-21. PMID 19837580 DOI: 10.1016/j.copbio.2009.09.005 |
0.434 |
|
| 2009 |
Woltjen K, Stanford WL. Preview. Inhibition of Tgf-beta signaling improves mouse fibroblast reprogramming. Cell Stem Cell. 5: 457-8. PMID 19896434 DOI: 10.1016/J.Stem.2009.10.007 |
0.351 |
|
| 2009 |
Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 458: 766-70. PMID 19252478 DOI: 10.1038/Nature07863 |
0.637 |
|
| 2009 |
Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature. 458: 771-5. PMID 19252477 DOI: 10.1038/nature07864 |
0.489 |
|
| 2008 |
Woltjen K, Ito K, Tsuzuki T, Rancourt DE. Orpheus recombination : a comprehensive bacteriophage system for murine targeting vector construction by transplacement. Methods in Molecular Biology (Clifton, N.J.). 435: 79-94. PMID 18370069 DOI: 10.1007/978-1-59745-232-8_6 |
0.533 |
|
| 2003 |
Thomas B, Woltjen K, Rancourt DE. Deep screening of recombination proficient bacteriophage libraries. Biotechniques. 34: 36-8, 40. PMID 12545535 |
0.469 |
|
| 2002 |
Woltjen K, Unger MW, Rancourt DE. Transplacement mutagenesis. A recombination-based in situ mutagenesis protocol. Methods in Molecular Biology (Clifton, N.J.). 182: 189-207. PMID 11768965 |
0.516 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Gao J, Makiyama T, Yamamoto Y, Kobayashi T, Aoki H, Maurissen TL, Wuriyanghai Y, Kashiwa A, Imamura T, Aizawa T, Huang H, Kohjitani H, Nishikawa M, Chonabayashi K, Fukuyama M, ... ... Woltjen K, et al. Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Circulation. Arrhythmia and Electrophysiology. e011387. PMID 36866681 DOI: 10.1161/CIRCEP.122.011387 |
0.299 |
|
| 2022 |
Takahashi K, Okubo C, Nakamura M, Iwasaki M, Kawahara Y, Tabata T, Miyamoto Y, Woltjen K, Yamanaka S. A stress-reduced passaging technique improves the viability of human pluripotent cells. Cell Reports Methods. 2: 100155. PMID 35474962 DOI: 10.1016/j.crmeth.2021.100155 |
0.293 |
|
| 2015 |
Kim SI, Oceguera-Yanez F, Hirohata R, Linker S, Okita K, Yamada Y, Yamamoto T, Yamanaka S, Woltjen K. KLF4 N-terminal variance modulates induced reprogramming to pluripotency. Stem Cell Reports. 4: 727-43. PMID 25772473 DOI: 10.1016/j.stemcr.2015.02.004 |
0.29 |
|
| 2019 |
Grajcarek J, Monlong J, Nishinaka-Arai Y, Nakamura M, Nagai M, Matsuo S, Lougheed D, Sakurai H, Saito MK, Bourque G, Woltjen K. Genome-wide microhomologies enable precise template-free editing of biologically relevant deletion mutations. Nature Communications. 10: 4856. PMID 31649251 DOI: 10.1038/s41467-019-12829-8 |
0.289 |
|
| 2023 |
Niwa R, Sakai K, Lung MSY, Matsumoto T, Mikawa R, Maehana S, Suzuki M, Yamamoto Y, Maurissen TL, Hirabayashi A, Noda T, Kubo M, Gotoh S, Woltjen K. ACE2 knockout hinders SARS-CoV-2 propagation in iPS cell-derived airway and alveolar epithelial cells. Frontiers in Cell and Developmental Biology. 11: 1290876. PMID 38149046 DOI: 10.3389/fcell.2023.1290876 |
0.282 |
|
| 2022 |
Ito K, Nagata K, Ohta S, Matsuda Y, Ukai T, Yasuda I, Ota A, Kobayashi R, Kabata M, Sankoda N, Maeda T, Woltjen K, Yang L, Maruyama R, Katayama R, et al. The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets. Cell Reports. 39: 110721. PMID 35476996 DOI: 10.1016/j.celrep.2022.110721 |
0.276 |
|
| 2017 |
Hashimoto K, Yamada Y, Semi K, Yagi M, Tanaka A, Itakura F, Aoki H, Kunisada T, Woltjen K, Haga H, Sakai Y, Yamamoto T, Yamada Y. Cellular context-dependent consequences of Apc mutations on gene regulation and cellular behavior. Proceedings of the National Academy of Sciences of the United States of America. PMID 28057861 DOI: 10.1073/pnas.1614197114 |
0.274 |
|
| 2018 |
Shibata H, Komura S, Yamada Y, Sankoda N, Tanaka A, Ukai T, Kabata M, Sakurai S, Kuze B, Woltjen K, Haga H, Ito Y, Kawaguchi Y, Yamamoto T, Yamada Y. In vivo reprogramming drives Kras-induced cancer development. Nature Communications. 9: 2081. PMID 29802314 DOI: 10.1038/s41467-018-04449-5 |
0.267 |
|
| 2018 |
Ikeda T, Hikichi T, Miura H, Shibata H, Mitsunaga K, Yamada Y, Woltjen K, Miyamoto K, Hiratani I, Yamada Y, Hotta A, Yamamoto T, Okita K, Masui S. Srf destabilizes cellular identity by suppressing cell-type-specific gene expression programs. Nature Communications. 9: 1387. PMID 29643333 DOI: 10.1038/s41467-018-03748-1 |
0.264 |
|
| 2018 |
Jo N, Sogabe Y, Yamada Y, Ukai T, Kagawa H, Mitsunaga K, Woltjen K, Yamada Y. Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modeling. Cancer Science. PMID 30588718 DOI: 10.1111/cas.13924 |
0.251 |
|
| 2015 |
Matsuda M, Koga M, Woltjen K, Nishida E, Ebisuya M. Synthetic lateral inhibition governs cell-type bifurcation with robust ratios. Nature Communications. 6: 6195. PMID 25652697 DOI: 10.1038/ncomms7195 |
0.244 |
|
| 2015 |
Jin Y, Elalaf H, Watanabe M, Tamaki S, Hineno S, Matsunaga K, Woltjen K, Kobayashi Y, Nagata S, Ikeya M, Kato T, Okamoto T, Matsuda S, Toguchida J. Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes. Plos One. 10: e0131998. PMID 26161668 DOI: 10.1371/journal.pone.0131998 |
0.242 |
|
| 2014 |
Sakuma T, Woltjen K. Nuclease-mediated genome editing: At the front-line of functional genomics technology Development Growth and Differentiation. 56: 2-13. PMID 24387662 DOI: 10.1111/dgd.12111 |
0.228 |
|
| 2017 |
Sone M, Morone N, Nakamura T, Tanaka A, Okita K, Woltjen K, Nakagawa M, Heuser JE, Yamada Y, Yamanaka S, Yamamoto T. Hybrid Cellular Metabolism Coordinated by Zic3 and Esrrb Synergistically Enhances Induction of Naive Pluripotency. Cell Metabolism. 25: 1103-1117.e6. PMID 28467928 DOI: 10.1016/j.cmet.2017.04.017 |
0.225 |
|
| 2013 |
Gallagher D, Norman AA, Woodard CL, Yang G, Gauthier-Fisher A, Fujitani M, Vessey JP, Cancino GI, Sachewsky N, Woltjen K, Fatt MP, Morshead CM, Kaplan DR, Miller FD. Transient maternal IL-6 mediates long-lasting changes in neural stem cell pools by deregulating an endogenous self-renewal pathway. Cell Stem Cell. 13: 564-76. PMID 24209760 DOI: 10.1016/J.Stem.2013.10.002 |
0.214 |
|
| 2019 |
Yagi M, Kabata M, Ukai T, Ohta S, Tanaka A, Shimada Y, Sugimoto M, Araki K, Okita K, Woltjen K, Hochedlinger K, Yamamoto T, Yamada Y. De Novo DNA Methylation at Imprinted Loci during Reprogramming into Naive and Primed Pluripotency. Stem Cell Reports. 12: 1113-1128. PMID 31056481 DOI: 10.1016/j.stemcr.2019.04.008 |
0.213 |
|
| 2022 |
Oceguera-Yanez F, Avila-Robinson A, Woltjen K. Differentiation of pluripotent stem cells for modeling human skin development and potential applications. Frontiers in Cell and Developmental Biology. 10: 1030339. PMID 36506084 DOI: 10.3389/fcell.2022.1030339 |
0.207 |
|
| 2021 |
Sankoda N, Tanabe W, Tanaka A, Shibata H, Woltjen K, Chiba T, Haga H, Sakai Y, Mandai M, Yamamoto T, Yamada Y, Uemoto S, Kawaguchi Y. Epithelial expression of Gata4 and Sox2 regulates specification of the squamous-columnar junction via MAPK/ERK signaling in mice. Nature Communications. 12: 560. PMID 33495473 DOI: 10.1038/s41467-021-20906-0 |
0.201 |
|
| 2019 |
Arai HN, Sato F, Yamamoto T, Woltjen K, Kiyonari H, Yoshimoto Y, Shukunami C, Akiyama H, Kist R, Sehara-Fujisawa A. Metalloprotease-Dependent Attenuation of BMP Signaling Restricts Cardiac Neural Crest Cell Fate. Cell Reports. 29: 603-616.e5. PMID 31618630 DOI: 10.1016/J.Celrep.2019.09.019 |
0.184 |
|
| 2017 |
Hirosawa M, Fujita Y, Parr CJC, Hayashi K, Kashida S, Hotta A, Woltjen K, Saito H. Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switch. Nucleic Acids Research. PMID 28525578 DOI: 10.1093/nar/gkx309 |
0.18 |
|
| 2023 |
Saito MK, Osawa M, Tsuchida N, Shiraishi K, Niwa A, Woltjen K, Asaka I, Ogata K, Ito S, Kobayashi S, Yamanaka S. A disease-specific iPS cell resource for studying rare and intractable diseases. Inflammation and Regeneration. 43: 43. PMID 37684663 DOI: 10.1186/s41232-023-00294-2 |
0.174 |
|
| 2016 |
Woltjen K, Yamamoto T, Kokubu C, Takeda J. Report on the Conference on Transposition and Genome Engineering 2015 (TGE 2015): advancing cutting-edge genomics technology in the ancient city of Nara. Genes to Cells : Devoted to Molecular & Cellular Mechanisms. PMID 27028186 DOI: 10.1111/gtc.12367 |
0.154 |
|
| 2017 |
Kondo T, Imamura K, Funayama M, Tsukita K, Miyake M, Ohta A, Woltjen K, Nakagawa M, Asada T, Arai T, Kawakatsu S, Izumi Y, Kaji R, Iwata N, Inoue H. iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease. Cell Reports. 21: 2304-2312. PMID 29166618 DOI: 10.1016/j.celrep.2017.10.109 |
0.149 |
|
| 2020 |
Reinhardt A, Kagawa H, Woltjen K. N-Terminal Amino Acids Determine KLF4 Protein Stability in 2A Peptide-Linked Polycistronic Reprogramming Constructs. Stem Cell Reports. 14: 520-527. PMID 32109368 DOI: 10.1016/j.stemcr.2020.01.014 |
0.146 |
|
| 2017 |
Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, Hotta A, Kondo T, Kitaoka S, Ohta A, Tanaka A, Watanabe D, Morita M, Takuma H, Tamaoka A, et al. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Science Translational Medicine. 9. PMID 28539470 DOI: 10.1126/Scitranslmed.Aaf3962 |
0.13 |
|
| 2024 |
Maurissen TL, Kawatou M, López-Dávila V, Minatoya K, Yamashita JK, Woltjen K. Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues. Scientific Reports. 14: 2586. PMID 38297132 DOI: 10.1038/s41598-024-52871-1 |
0.12 |
|
| 2023 |
Kawasaki S, Ono H, Hirosawa M, Kuwabara T, Sumi S, Lee S, Woltjen K, Saito H. Programmable mammalian translational modulators by CRISPR-associated proteins. Nature Communications. 14: 2243. PMID 37076490 DOI: 10.1038/s41467-023-37540-7 |
0.114 |
|
| 2022 |
Kashiwa A, Makiyama T, Kohjitani H, Maurissen TL, Ishikawa T, Yamamoto Y, Wuriyanghai Y, Gao J, Huang H, Imamura T, Aizawa T, Nishikawa M, Chonabayashi K, Mishima H, Ohno S, ... ... Woltjen K, et al. Disrupted Cav1.2 selectivity causes overlapping long QT and Brugada syndrome phenotypes in the CACNA1C-E1115K iPS cell model. Heart Rhythm. PMID 36007726 DOI: 10.1016/j.hrthm.2022.08.021 |
0.104 |
|
| 2018 |
Woltjen K, Bortvin A. Editorial overview: Embroidering the canvas of life. Current Opinion in Genetics & Development. 52: ii-iv. PMID 30470343 DOI: 10.1016/J.Gde.2018.11.002 |
0.01 |
|
| Hide low-probability matches. |